15O-水PET全局心肌血流储备的预后价值:基于风险的分层切点建议
该回顾性研究纳入783例已知或疑似慢性冠脉综合征患者,按全局心肌血流储备(MFR)分为>3.5、2.5-3.5、1.5-<2.5和<1.5四组,评估主要不良心脏事件(MACE)。中位随访3.5年发生129例MACE,MACE风险随MFR下降而逐步升高,多变量调整后组间差异仍显著,提示可采用四层MFR分类进行风险分层。
要点
- MFR>3.5组年化MACE率0.6/100人年,前2.5年无MACE发生。
- MFR 2.5-3.5组年化MACE率3.1/100人年,HR 5.4(95%CI 2.3-13)。
- MFR<1.5组年化MACE率13.7/100人年,HR 24(95%CI 10-59)。
核心结论
- MACE风险随全局MFR下降而逐步升高,建议采用四层MFR分类报告风险,以MFR>3.5提示低风险。
研究设计与样本
- 回顾性纳入783例已知或疑似慢性冠脉综合征且接受临床指征15O-水PET的患者,按全局MFR分为>3.5、2.5-3.5、1.5-<2.5和<1.5四组,中位随访3.5年。
主要发现
- 共发生129例MACE,MFR>3.5组(n=204)年化MACE率0.6/100人年,前2.5年无MACE。
- MFR 2.5-3.5组(n=310)年化MACE率3.1/100人年,HR 5.4(95%CI 2.3-13)。
- MFR 1.5-<2.5组(n=201)年化MACE率6.8/100人年,HR 12(95%CI 5.1-28)。
- MFR<1.5组(n=68)年化MACE率13.7/100人年,HR 24(95%CI 10-59)。
- 多变量调整后组间差异仍显著(P≤0.029)。
关键数值与推荐
- 全局MFR四层分类:>3.5、2.5-3.5、1.5-<2.5、<1.5。
- MACE定义:全因死亡或因急性心肌梗死、不稳定型心绞痛或急性心力衰竭住院。
临床怎么用
- 对接受15O-水PET心肌灌注显像的患者,可按全局MFR四层分类(>3.5、2.5-3.5、1.5-<2.5、<1.5)报告风险。
- MFR>3.5提示低风险,MFR 2.5-3.5为中间风险灰区,MFR<2.5风险更高。
局限性
- 本研究为回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A global myocardial flow reserve (MFR) threshold of 2.5 is clinically used to define normal vasodilatory capacity with 15O-water positron emission tomography (PET) myocardial perfusion imaging but lacks prognostic validation. Since mean global MFR exceeds 3.5 in healthy individuals, the 2.5-3.5 range may represent an intermediate-risk "gray zone." We aimed to evaluate a 4-tiered global MFR categorization for risk stratification. METHODS: We retrospectively included patients with known or suspected chronic coronary syndromes who underwent clinically indicated 15O-water PET. Patients were stratified into four groups by global MFR: >3.5, 2.5-3.5, 1.5-<2.5, and <1.5. Major adverse cardiac events (MACEs) were defined as all-cause death or hospitalization for acute myocardial infarction, unstable angina, or acute heart failure. Prognostic value was evaluated using Cox hazard ratios (HRs; [95% confidence interval]). RESULTS: Among 783 consecutive patients (median age: 68; 45% female), 129 MACEs occurred over a median follow-up of 3.5 years. Patients with an MFR >3.5 (n = 204) exhibited an annualized MACE rate of 0.6 per 100 person-years, with no MACE occurring during the first 2.5 years. An MFR of 2.5-3.5 (n = 310) had a 5-fold higher annualized MACE rate (3.1 per 100 person-years; HR: 5.4 [2.3-13]), increasing to 6.8 for an MFR measuring 1.5-<2.5 (n = 201; HR: 12 [5.1-28]) and 13.7 for an MFR <1.5 (n = 68; HR: 24 [10-59]). Group differences remained significant after multivariable adjustment (P ≤ 0.029). CONCLUSIONS: Risk of MACE increases progressively with declining global MFR. We propose a 4-tiered categorization of MFR for reporting risk, using an MFR >3.5 to indicate a low-risk profile.
引用
- Svanström P, Kero T, Sigfridsson J, et al. Prognostic value of 15O-water PET global myocardial flow reserve: Proposed risk-based cutoffs. J Nucl Cardiol. 2026. PMID: 42336131. doi:10.1016/j.nuclcard.2026.102795
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。